title: GLI1, a master regulator of the hallmark of pancreatic cancer.
abstract: Hedgehog signaling is highly conserved across species and governs proper embryonic development. Germline gene mutations that reduce this signaling activity cause a variety of developmental abnormalities such as holoprosencephaly, while those that enhance Hedgehog signaling activity induce a tumor-predisposition condition Nevoid basal cell carcinoma syndrome. Furthermore, dysregulated activation of Hedgehog signaling has been recognized in various sporadic malignancies, including pancreatic adenocarcinoma. Pancreatic adenocarcinoma develops through a multistep carcinogenesis starting with oncogenic mutation of the KRAS gene. During this process, precancerous or cancer cells secrete Hedgehog ligand proteins to promote characteristic desmoplastic stroma around the cells, which in turn activates the expression of the downstream transcription factor GLI1 inside the cells. The quantitative and spatiotemporal dysregulation of GLI1 subsequently leads to the expression of transcriptional target genes of GLI1 that govern the hallmark of malignant properties. Here, after a brief introductory outline, a perspective is offered of Hedgehog signaling with a special focus on the role of GLI1 in pancreatic carcinogenesis.
authors.affiliation: Department of Pathology, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan.
authors.forename: Kenji
authors.initials: K
authors.lastname: Kasai
mesh_terms: D053823:Hedgehog Proteins / Q000502:physiology; D006801:Humans; D010190:Pancreatic Neoplasms / Q000235:genetics* / Q000473:pathology / Q000503:physiopathology*; D015398:Signal Transduction; D000071676:Zinc Finger Protein GLI1 / Q000235:genetics / Q000378:metabolism*
chemical_list: D053823:Hedgehog Proteins; D000071676:Zinc Finger Protein GLI1
keywords: GLI1; Hedgehog; pancreatic cancer; target gene; transcription factor